Background: Normally, gelsolin functions in plasma as part of the actin-sca
venging system to assemble and disassemble actin filaments, The Asp187 -->
Asn (D187N) and Asp187 --> Tyr (D187Y) gelsolin mutations facilitate two pr
oteolytic cuts in the parent protein generating a 71-residue fragment that
forms amyloid fibrils in humans, putatively causing Finnish type familial a
myloidosis (FAF). We investigated the role of the D187N mutation in amyloid
ogenicity using biophysical studies in vitro.
Results: Both the recombinant wild-type and D187N FAF-associated gelsolin f
ragments adopt an ensemble of largely unfolded structures that do not self-
associate into amyloid at pH 7.5, incubation of either fragment at low pHs
(6.0-4.0) leads to the formation of well-defined fibrils within 72 hours, h
owever.
Conclusions: The D187N mutation has been suggested to destabilize the struc
ture of the gelsolin parent protein (specifically domain 2), facilitating t
wo proteolytic cleavage events. Our studies demonstrate that generating the
largely unstructured peptide is not sufficient alone for amyloid formation
in vitro (on a time scale of months), A drop in pH or an analogous environ
mental change appears necessary to convert the unstructured fragment into a
myloid fibrils, probably through an associative mechanism, The wild-type ge
lsolin fragment will make amyloid fibrils from pH 6 to 4 in vitro, but neit
her the wildtype fragment nor fibrils have been observed in vivo. It is pos
sible that domain 2 of wild-type gelsolin is stable in the context of the w
hole protein and not susceptible to the proteolytic degradation that afford
s the 71-residue FAF-associated peptide.